Explained herein are pharmaceutical packaging systems which stop oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-delicate drugs, such programs which include a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with pretty minimal permeability to oxygen and compris